TP53 and colorectal carcinoma: Kushen injection is a commonly used adjuvant to CRC chemotherapy, and combined with cisplatin, it exerts synergistic antitumor activity against p53-R273H/P309S mutant CRC cells through the induction of apoptosis [116].